(4S,4'S)-4,4'-Diisopropyl-1,1'-di-m-tolyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 100mg

2-Thioxo-1,3-thiazolidin-4-one, 97.0%, 100g

4-Bromopyridine-2-carboxaldehyde, 98.0%, 5g

N,N-Diethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 250mg

5-Bromo-2'-deoxyuridine, 95.0%, 10g

Tri(2-Furyl)phosphine, 97.0%, 100g

Acide 4-hydrazinebenzoïque, min 97 %, pour la synthèse, 50 g, emballage en verre

N-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOANILINO)-6-METHOXYPHENYL]-1-[(2S)-2,3-DIHYDROXYPROPYL]CYCLOPROPANE-1-SULFONAMIDE, 95%, 250mg

4-Fluoro-1H-pyrazole, 95.0%, 250mg

4-Methyl-3-nitropyridine, 98.0%, 500g

1-BROMO-4-FLUORO-5-ISOPROPYL-2-METHOXYBENZENE, 95.0%, 1g

2,3-Diamino-5-methylpyridine, 95.0%, 1g

6-Fluoroindole-3-carboxaldehyde, 98.0%, 5g